Gritstone bio, Inc.
Gritstone bio, Inc. (GRTS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
grts · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Gritstone bio, Inc. (GRTS) measures how much investors pay for each dollar of the company's trailing earnings. GRTS's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$1.20.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2016 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Gritstone bio, Inc.You GRTS | $4M | N/A | — | -$1.20 |
 Affimed N.V. AFMD | $3M | N/A | — | -$7.09 |
 Aptose Biosciences Inc. APTO | $4M | N/A | — | $0.00 |
 Atreca, Inc. BCEL | $4M | N/A | — | -$2.52 |
 Gamida Cell Ltd. GMDA | $4M | N/A | — | -$0.42 |
 Idera Pharmaceuticals, Inc. IDRA | $0M | N/A | — | -$7.17 |
 Onconetix, Inc. ONCO | $0M | N/A | — | -$4.28 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $-1.20 | — | |
2022-12-31 FY2022 | — | $-1.24 | — | |
2021-12-31 FY2021 | — | $-0.95 | — | |
2020-12-31 FY2020 | — | $-2.77 | — | |
2019-12-31 FY2019 | — | $-2.71 | — | |
2018-12-31 FY2018 | — | $-7.26 | — | |
2017-12-31 FY2017 | — | $-2.06 | — | |
2016-12-31 FY2016 | — | $-0.93 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Gritstone bio, Inc. (GRTS) measures how much investors pay for each dollar of the company's trailing earnings. GRTS's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$1.20.
Frequently asked questions
GRTS pe ratio · 6 questionsGRTS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.03 and TTM EPS of -$1.20. Data sourced from Financial Modeling Prep via GRTS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Gritstone bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09